AUTHENTICATED
`US, GOVERNMENT
`INFORMATION
`GPa,
`
`Federal Register/Vol. 89, No. 67/Friday, April 5, 2024/ Notices
`
`States within a reasonably foreseeable
`time.
`
`Background
`The Commission instituted this
`review on October 2, 2023 (88 FR
`67809) and determined on January 5,
`2024 that it would conduct an expedited
`review (89 FR 3427, January 18, 2024).
`The Commission madethis
`determination pursuantto section
`751(c) of the Act (19 U.S.C. 1675(c)). It
`completed andfiled its determination in
`this review on April 1, 2024. The views
`of the Commission are contained in
`USITC Publication 5501 (April 2024),
`entitled Xanthan Gum from China:
`Investigation No. 731-TA-1203 (Second
`Review).
`By order of the Commission.
`Issued: April 1, 2024.
`Lisa Barton,
`Secretary to the Commission.
`[FR Doc. 2024-07214 Filed 44-24; 8:45 am]
`BILLING CODE 7020-02-P
`
`
`INTERNATIONAL TRADE
`COMMISSION
`
`Notice of Receipt of Complaint;
`Solicitation of Comments Relating to
`the Public Interest
`
`AGENCY: U.S. International Trade
`Commission.
`ACTION: Notice.
`
`SUMMARY:Notice is hereby given that
`the U.S. International Trade
`Commission has received a complaint
`Certain Cameras, Camera Systems, and
`Accessories Used Therewith, DN 3736;
`the Commission is soliciting comments
`on any public interest issues raised by
`the complaint or complainant’s filing
`pursuant to the Commission’s Rules of
`Practice and Procedure.
`FOR FURTHER INFORMATION CONTACT: Lisa
`R. Barton, Secretary to the Commission,
`U.S. International Trade Commission,
`500 E Street SW, Washington, DC
`20436, telephone (202) 205-2000. The
`public version of the complaint can be
`accessed on the Commission’s
`Electronic Document Information
`System (EDIS) at https://edis.usitc.gov.
`For help accessing EDIS, please email
`EDIS3Help@usitc.gov.
`Generalinformation concerning the
`Commission mayalso be obtained by
`accessingits internet server at United
`States International Trade Commission
`(USITC)at hitps://www.usitic.gov. The
`public record for this investigation may
`be viewed on the Commission’s
`Electronic Document Information
`System (EDIS) at https://edis.usitc.gov.
`Hearing-impaired persons are advised
`
`that information on this matter can be
`obtained by contacting the
`Commission’s TDD terminal on (202)
`205-1810.
`
`SUPPLEMENTARY INFORMATION: The
`Commission has received a complaint
`and a submission pursuantto § 210.8(b)
`of the Commission’s Rules of Practice
`and Procedurefiled on behalf of GoPro,
`Inc. on March 29, 2024. The complaint
`alleges violations of section 337 of the
`Tariff Act of 1930 (19 U.S.C. 1337) in
`the importation into the United States,
`the sale for importation, and the sale
`within the United States after
`importation of certain cameras, camera
`systems, and accessories used
`therewith. The complaint namesas
`respondents: Arashi Vision Inc. d/b/a
`Insta360 of China; and Arashi Vision
`(U.S.) LLC d/b/a Insta360 ofIrvine, CA.
`The complainant requests that the
`Commission issue a general exclusion
`orderor, in the alternative, limited
`exclusion orders and cease anddesist
`orders, and impose a bond upon
`respondentalleged infringing articles
`during the 60-day Presidential review
`period pursuantto 19 U.S.C. 1337(j).
`Proposed respondents, other
`interested parties, and membersof the
`public are invited to file comments on
`any public interest issues raised by the
`complaint or § 210.8(b) filing.
`Comments should address whether
`issuanceofthe relief specifically
`requested by the complainantin this
`investigation would affect the public
`health and welfare in the United States,
`competitive conditions in the United
`States economy, the production oflike
`or directly competitive articles in the
`United States, or United States
`consumers.
`
`In particular, the Commission is
`interested in commentsthat:
`(i) explain how thearticles potentially
`subject to the requested remedial orders
`are used in the United States;
`(ii) identify any public health,safety,
`or welfare concernsin the United States
`relating to the requested remedial
`orders;
`(iii) identify like or directly
`competitive articles that complainant,
`its licensees, or third parties make in the
`United States which could replace the
`subjectarticles if they were to be
`excluded;
`(iv) indicate whether complainant,
`complainant’s licensees, and/or third
`party suppliers have the capacity to
`replace the volumeofarticles
`potentially subject to the requested
`exclusion order and/or a cease and
`desist order within a commercially
`reasonable time; and
`
`(v) explain how the requested
`remedial orders would impact United
`States consumers.
`Written submissions on the public
`interest mustbefiled no later than by
`close of business, eight calendar days
`after the date of publication ofthis
`notice in the Federal Register. There
`will be further opportunities for
`commenton the public interest after the
`issuance of anyfinal initial
`determinationin this investigation. Any
`written submissions on other issues
`mustalso be filed by no later than the
`close of business, eight calendar days
`after publication of this notice in the
`Federal Register. Complainant mayfile
`replies to any written submissions no
`later than three calendar days after the
`date on which anyinitial submissions
`were due, notwithstanding § 201.14(a)
`of the Commission’s Rules of Practice
`and Procedure. No other submissions
`will be accepted, unless requested by
`the Commission. Any submissions and
`replies filed in responseto this Notice
`are limited to five (5) pages in length,
`inclusive of attachments.
`Personsfiling written submissions
`mustfile the original document
`electronically on or before the deadlines
`stated above. Submissions should refer
`to the docket number(‘‘Docket No.
`3736’’) in a prominent place on the
`cover page and/orthefirst page. (See
`Handbookfor Electronic Filing
`Procedures, Electronic Filing
`Procedures1),
`Please note the Secretary’s Office will
`accept only electronic filings during this
`time. Filings must be made through the
`Commission’s Electronic Document
`Information System (EDIS,hitps://
`edis.usitc.gov). No in-person paper-
`basedfilings or paper copies of any
`electronic filings will be accepted until
`further notice. Persons with questions
`regarding filing should contact the
`Secretary at EDIS3Help@usiic.gov.
`Any person desiring to submit a
`documentto the Commission in
`confidence must request confidential
`treatment. All such requests should be
`directed to the Secretary to the
`Commission and mustincludea full
`statementof the reasons why the
`Commission should grant such
`treatment. See 19 CFR 201.6. Documents
`for which confidential treatment by the
`Commission is properly sought will be
`treated accordingly. All information,
`including confidential business
`information and documents for which
`confidential treatment is properly
`sought, submitted to the Commission for
`
`1Handbookfor Electronic Filing Procedures:
`https://www.usitc.gov/documents/handbook_on_
`filing_procedures.pdf.
`
`

`

`24035
`Federal Register/Vol. 89, No. 67/Friday, April 5, 2024/ Notices
`
`purposesof this Investigation may be
`disclosed to and used: (i) by the
`Commission, its employees and Offices,
`and contract personnel(a} for
`developing or maintaining the records
`of this or a related proceeding,or (b) in
`internal investigations, audits, reviews,
`and evaluationsrelating to the
`programs, personnel, and operations of
`the Commission including under 5
`U.S.C. Appendix 3;or (ii) by U.S.
`government employees andcontract
`personnel,? solely for cybersecurity
`purposes. All nonconfidential written
`submissions will be available for public
`inspection at the Office of the Secretary
`and on EDIS.3
`This action is taken underthe
`authority of section 337 of the Tariff Act
`of 1930, as amended (19 U.S.C. 1337),
`and of §§ 201.10 and 210.8(c) of the
`Commission’s Rules of Practice and
`Procedure (19 CFR 201.10, 210.8(c)).
`
`By order of the Commission.
`Issued: April 1, 2024.
`Lisa Barton,
`Secretary to the Commission.
`[FR Doc. 2024-07215 Filed 44-24; 8:45 am]
`BILLING CODE 7020-02-P
`
`
`Drug Enforcement Administration
`
`[Docket No. 23-64]
`
`Carolina medical license expired. RD,at
`4.4
`According to South Carolina online
`records, of which the Agency takes
`official notice, Respondent’s South
`Carolina controlled substance
`registration is expired.> SC DHEC
`Bureau of Drug Control, Controlled
`Substances Registration Verification,
`https://.dhec.sc.gov//Licensing/Home/
`Verify (last visited date of signature of
`this Order). Further, Respondent’s
`South Carolina medicallicenseis listed
`as “lapsed.” South Carolina Board of
`Medical Examiners, Licensee Lookup,
`hittps://verify.lronline.com/LicLookup/
`Med/Med.aspx(last visited date of
`signature of this Order).
`Accordingly, the Agency finds that
`Respondentis not currently licensed to
`engage in the practice of medicine nor
`to handle controlled substances in
`South Carolina, the state in which she
`is registered with the DEA.
`Discussion
`
`On September20, 2023, Respondent
`requested a hearing. On October13,
`2023, the Governmentfiled a Motion for
`Summary Disposition only pertaining to
`the allegation that Respondent lacks
`state authority to handle controlled
`substances.1 See Government’s Notice of
`Filing of Evidence and Motion for
`Summary Disposition (Motion for
`Summary Disposition), dated October
`13, 2023.2 Respondent did not respond
`to the Government’s Motion for
`Summary Disposition. On October 23,
`2023, Administrative Law Judge Paul E.
`Soeffing (the ALJ) granted the
`Government’s Motion for Summary
`Disposition and recommendedthe
`revocation of Respondent’sregistration,
`finding that because Respondentlacks
`state authority to handle controlled
`substances in South Carolina, the state
`in which sheis registered with DEA,
`“there is no other fact of consequence
`for this tribunal to decide in orderto
`determine whetheror notsheis entitled
`to hold a COR.” Order Granting the
`Pursuant to 21 U.S.C. 824(a)(3), the
`Government’s Motion for Summary
`Attorney Generalis authorized to
`Disposition, and Recommended
`suspend orrevokea registration issued
`Rulings, Findings of Fact, Conclusions
`under section 823 of the Controlled
`of Law, and Decision of the
`Substances Act (CSA) ‘“‘upon a finding
`Administrative Law Judge (RD), at 6.
`that the registrant.
`.
`. has had his State
`Respondentdid notfile exceptions to
`license or registration suspended...
`the RD.
`DEPARTMENTOF JUSTICE
`[or] revoked.
`.
`. by competent State
`Having reviewedthe entire record, the
`authority and is no longer authorized by
`Agency adopts and hereby incorporates
`State law to engage inthe...
`by reference the entirety of the ALJ’s
`dispensing of controlled substances.”
`rulings, findings of fact, conclusions of
`With respectto a practitioner, the DEA
`law, and recommendedsanction as
`hasalso long held that the possession of
`found in the RD and summarizes and
`authority to dispense controlled
`substances underthe lawsofthe state in
`expands uponportionsthereofherein.
`which a practitioner engages in
`Findings of Fact
`professional practice is a fundamental
`The Governmentasserts that on
`condition for obtaining and maintaining
`a practitioner’s registration. See, e.g.,
`October 1, 2022, Respondent’s South
`Carolina controlled substance
`James L. Hooper, M.D., 76 FR 71371,
`71372 (2011), pet. for rev. denied, 481
`registration expired. RD,at 3—-4.3
`Further, the Governmentasserts that on
`June 30, 2023, Respondent’s South
`
`Traesa A. Brown, M.D.; Decision and
`Order
`
`On August 31, 2023, the Drug
`Enforcement Administration (DEA or
`Government) issued an Order to Show
`Cause and Immediate Suspension of
`Registration (OSC/ISO) to Traesa A.
`Brown, M.D. (Respondent) of Florence,
`South Carolina. OSG, at 1, 5. The OSC/
`ISO informed Respondentof the
`immediate suspension of her DEA
`Certificate of Registration (registration
`or COR), Control No. BB9937624,
`pursuantto 21 U.S.C. 824(d), alleging
`that Respondent’s continuedregistration
`constitutes ‘‘‘an imminent dangerto the
`public health or safety.’ ”Id. at 1
`(quoting 21 U.S.C. 824(d)). The OSC/
`ISO also proposedthe revocation of
`Respondent’sregistration, alleging that
`Respondent’s continuedregistration is
`inconsistent with the public interest and
`alleging that Respondenthasnostate
`authority to handle controlled
`substances. Id.(citing 21 U.S.C.
`823(g)(1), 824(a)(3), 824(a)(4)).
`
`2 All contract personnelwill sign appropriate
`nondisclosure agreements.
`3 Electronic Document Information System
`(EDIS): https://edis.usitc.gov.
`
`1 This suggests that the Government has dropped
`the public interest allegation included in the OSC/
`ISO; as such, the Agency will only consider the lack
`of state authority allegation from the OSC/ISO.
`2 The Governmentoriginally filed a Motion for
`Summary Disposition on October 12, 2023, and
`therein asserted that Respondenthadfailed to
`timely file an Answerto the allegations in the OSC/
`ISO.RD,at 2 n.4; Motion for Summary Disposition,
`dated October 12, 2023, at 3-4. Later on October 12,
`2023, the Government was informed that
`Respondenthad filed an Answer on October 10,
`2023, and was provided with a copy of
`Respondent’s Answer. RD,at 2 0.4. On October 13,
`2023, the Governmentfiled its amended Motion for
`Summary Disposition, referenced in this Decision,
`with revisions based onits receipt of the copy of
`Respondent’s Answer. Id.; see also Motion for
`Summary Disposition, dated October 13, 2023.
`3 See also Motion for Summary Disposition, dated
`October 13, 2023, Exhibit (GX) 1; Motion for
`Summary Disposition, dated October 13, 2023, at 4—
`5.
`
`4 See also Motion for Summary Disposition, dated
`October 13, 2023, at 4. As noted by the AL], the
`Governmentdid not submit documentary evidence
`regarding the status of Respondent’s South Carolina
`medical license as they had for Respondent’s South
`Carolina controlled substance registration, see
`supra n.3. RD,at 40.8,
`5 Under the Administrative Procedure Act, an
`agency “may take official notice of facts at any stage
`in a proceeding—evenin thefinal decision.”
`United States Departmentof Justice, Attorney
`General’s Manual on the Administrative Procedure
`Act 80 (1947) (Wm. W. Gaunt & Sons,Inc., Reprint
`1979). Pursuant to 5 U.S.C. 556(e), “[w]hen an
`agency decisionrests on official notice of a material
`fact not appearing in the evidencein the record, a
`party is entitled, on timely request, to an
`opportunity to show the contrary.” Accordingly,
`Respondent may dispute the Agency’s finding by
`filing a properly supported motion for
`reconsideration offindings of fact within fifteen
`calendar daysofthe date of this Order. Any such
`motion and responseshall be filed and served by
`email to the other party and to Office of the
`Administrator, Drug Enforcement Administration at
`dea.addo.attorneys@dea.gov.
`
`